Condition
OHT - Ocular Hypertension
Total Trials
5
Recruiting
1
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 2 (1)
P 4 (1)
Trial Status
Completed3
Recruiting1
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07354516Phase 2Recruiting
Study of QLS-111-FDC in Open-Angle Glaucoma or Ocular Hypertension
NCT04412096Phase 4Completed
Aqueous Humor Dynamic Components That Determine Intraocular Pressure Variance
NCT03931317Not ApplicableCompleted
Study Comparing the Effects of Latanoprostene Bunod and Timolol on Retinal Blood Vessel Density and Visual Acuity
NCT04064918Not ApplicableWithdrawn
Effects of Netarsudil and Timolol on Retinal Blood Vessel Density and Visual Acuity
NCT04888156Completed
Impact of Self-tonometry on Glaucoma Treatment Decision.
Showing all 5 trials